1 booster (and Moderna’s, though the TGA has not approved this one at ... Most recently we’ve faced a soup of Omicron sub-variants, including JN.1. Since JN.1 was first detected in August 2023, this ...

For young, healthy people who may be wondering, “do I need a COVID booster at all?”, having one annually is sensible.

Stacker consulted research from Yale Medical School and the World Health Organization to find how SARS-CoV-2 has evolved ...

Both Moderna and Pfizer-BioNTech manufacture the COVID vaccine ... but they're not immune to the virus. "At the height of the ...

Moderna reported a surprise third-quarter profit on Thursday, driven by cost cutting and higher-than-expected sales of its ...

How are the new vaccines different from last fall’s boosters? The updated mRNA vaccines from Moderna and Pfizer-BioNTech target the KP.2 strain, part of the Omicron lineage that began spreading last ...

Moderna: Moderna was granted FDA Emergency Use ... Updated data for Davidson County Across the United States, KP.3.1.1 of the Omicron family, is the leading variant, accounting for 57% of cases ...

Moderna: Moderna was granted FDA Emergency Use ... 2 and KP.3. Across the United States, KP.3.1.1 of the Omicron family, is the leading variant, accounting for 57% of cases throughout the two ...

An abundance of evidence indicates the mRNA COVID-19 vaccines are remarkably safe and work well to protect against severe disease. But last month, the state of Florida issued updated vaccine guidance ...

Children between the ages of 6 months and 4 years who have not been vaccinated are considered “up to date” once they have ...

On Monday, Merck & Co Inc (NYSE:MRK) and Moderna, Inc. (NASDAQ:MRNA) announced the initiation of INTerpath-009, a pivotal Phase 3 trial of V940 (mRNA-4157). V940 is an investigational ...

The COVID-19 vaccine is the updated Omicron KP.2 shot, which targets the latest virus variants. Moderna’s KP.2 is available for those six months and older, while Pfizer’s KP.2 is available for those ...